PHAXIAM Therapeutics ADR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PHXM and buy or sell other stocks, ETFs, and their options commission-free!

About PHXM

PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. 

CEO
Thibaut du Fayet, MBA
CEOThibaut du Fayet, MBA
Employees
Employees
Headquarters
Lyon, Auvergne-Rhone-Alpes
HeadquartersLyon, Auvergne-Rhone-Alpes
Founded
2004
Founded2004
Employees
Employees

PHXM Key Statistics

Market cap
29.46M
Market cap29.46M
Price-Earnings ratio
-0.83
Price-Earnings ratio-0.83
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.10
52 Week high$3.10
52 Week low
$3.10
52 Week low$3.10

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.